GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges

by Robinson, H, Kannanganat, S, Gangadhara, S, Lai, L, Yu, T, Kozlowski, P, Earl, P, Moss, B, Amara, RR
Published 2012

CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections

by Kwa, S, Sadagopal, S, Hong, J, Gangadhara, S, Basu, R, Lai, L, Iyer, S, Araki, K, Earl, PL, Wyatt, L, Villinger, F, Moss, B, Ahmed, R, Amara, RR
Published 2012